Wednesday, March 23, 2011

Medical News

Medical News


Symptoms and QoL “determinants of depression in COPD”

Posted: 23 Mar 2011 05:00 PM PDT

The prevalence of depression is increased in patients with chronic obstructive pulmonary disease and is significantly associated with disease symptoms and quality of life, research shows.

Everyday activities impaired in community-dwelling schizophrenia patients

Posted: 23 Mar 2011 05:00 PM PDT

Community-dwelling patients with schizophrenia show major impairments in activities of daily living and social functioning, study results have shown.

Pediatric cyclothymia is distinct subtype of bipolar disorder

Posted: 23 Mar 2011 05:00 PM PDT

Cyclothymia is a valid and distinct diagnostic entity among children and adolescents in much the same sense as the adult form of the disorder, study results show.

Sirolimus-eluting stent linked to low adverse outcome risk

Posted: 22 Mar 2011 05:00 PM PDT

Findings from a multinational study indicate that stent thrombosis and major bleeding are uncommon events in cardiac patients treated with sirolimus-eluting stents.

Hormone therapy for prostate cancer linked to significant weight gain

Posted: 22 Mar 2011 05:00 PM PDT

Study results indicate that prostate cancer patients treated with androgen deprivation therapy after surgical removal of their prostate are likely to experience significant weight gain.

Soybean oil intake may influence tissue fatty acid levels

Posted: 22 Mar 2011 05:00 PM PDT

Researchers suggest that an increase in the consumption of soybean oil over time is partly responsible for significant changes in human tissue concentrations of essential fatty acids.

<i>CETP</i>, <i>LIPC</i> polymorphisms affect atherosclerotic risk

Posted: 22 Mar 2011 05:00 PM PDT

Imbalances between cholesteryl ester transfer protein and hepatic lipase activities may modulate the risk for carotid atherosclerosis, research suggests.

Paclitaxel and sirolimus stents result in similar 4-year outcomes in diabetics

Posted: 22 Mar 2011 05:00 PM PDT

Long-term results from the DES-DIABETES trial show no additional benefits of using sirolimus-eluting stents over paclitaxel-eluting stents for revascularization in patients with diabetes and cardiovascular disease.

Co-existing hypertension may explain significant excess CV risk in diabetics

Posted: 22 Mar 2011 05:00 PM PDT

Co-existing hypertension may explain a significant amount of the excess cardiovascular risk experienced by patients with diabetes, suggest study findings.

Measure of fitness may improve CVD risk classification

Posted: 22 Mar 2011 05:00 PM PDT

US researchers report that adding a single measurement of fitness to traditional cardiovascular disease-related mortality risk prediction models may improve the accuracy of such models when used in low-risk asymptomatic individuals.

Sirolimus-eluting stent linked to low adverse outcome risk

Posted: 22 Mar 2011 05:00 PM PDT

Findings from a multinational study indicate that stent thrombosis and major bleeding are uncommon events in cardiac patients treated with sirolimus-eluting stents.

No comments:

Post a Comment